I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stages of disease and to providing compassionate care for patients and their families. My research focuses on developing innovative and effective ways to harness the body’s immune system to fight cancer. I am a member of the Immunotherapeutics Group, where we design and lead early-phase clinical trials of immunotherapies for patients with a variety of different cancers.
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Matthew D. Hellmann
Clinical Trials Co-Investigated by Matthew D. Hellmann
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.Learn more